Table 2.
Proposed list of 18 indicators to measure the outputs and impact of EU-funded biomedical research activities on selected biomedical research area(s).
| Category | Indicator | |
|---|---|---|
| Funding/Economic | 1 | Number of projects within a certain EU framework programme (FP) |
| 2 | Value of projects within a certain EU FP | |
| 3 | Value of projects from other EU (but non-EC) funding bodies | |
| Dissemination | 4 | Number of publications (in the frame of a certain research FP) on new scientific insights (e.g., new biomarker, new signaling pathways or mode of action) and whether they were obtained using animal vs. non-animal approaches |
| 5 | Number of publications (in the frame of a certain research FP) on new methods, tools, and approaches (e.g., new diagnostic tool, new treatment approach, new preventive measure) and whether they were obtained using animal vs. non-animal methods and approaches | |
| 6 | Number of citations of papers above (i.e., describing either a new scientific insight, or new methods, tools, and approaches) | |
| Scientific and technological | 7 | Number of patents and whether they were based on animal vs. non-animal findings (e.g., suitable to study selected diseases and/or to test new drugs) |
| 8 | Number of diagnostic tools and whether they were based on animal vs. non-animal findings | |
| 9 | Number of approved drugs, treatments, or medical devices and whether they were based on animal vs. non-animal findings | |
| 10 | Number of clinical trials for new drugs and whether they were based on animal vs. non-animal findings | |
| 11 | Number of new preventive measures and whether they were based on animal vs. non-animal findings | |
| Regulatory and policy | 12 | Number of public health guidance values/options in regulatory medical-health sectors (e.g., by EMA, national governments, OECD, etc.) |
| 13 | Number of new regulatory policy actions | |
| 14 | Number of new non-regulatory targeted policy actions at the national and EU level | |
| Public and social engagement | 15 | Level of public/social engagement (to disseminate knowledge derived from EU-funded research) |
| 16 | Global indicator(s): Public health trends on selected diseases (e.g., disease prevalence, mortality rate, disease-associated risk factors) | |
| Education, training, and job opportunities | 17 | New job opportunities resulting from EU-funded research activities |
| 18 | New learning opportunities resulting from EU-funded research activities | |
EMA: European Medicines Agency; OECD: Organization for Economic Co-operation and Development.